University of Minnesota

Christopher M Staley

Michael J Sadowsky

Alexander Khoruts

Matthew J Hamilton

The present disclosure provides compositions and methods for treatinginfection (CDI) including primary and recurrent CDI. In particular, the compositions and methods described herein are capable of achieving a CDI clearance rate of at least 80% through a single oral dose of a pharmaceutical composition comprising a freeze-dried fecal microbiota preparation.

Compositions and methods fortreatment

The present disclosure provides compositions and methods for treatinginfection (CDI) including primary and recurrent CDI. In particular, the compositions and methods described herein are capable of achieving a CDI clearance rate of at least 80% through a single oral dose of pharmaceutical composition comprising a freeze-dried fecal microbiota preparation.

Growing community of inventors

Saint Paul, MN, United States of America

Christopher M Staley